Sep 19, 2016

TenNor of Suzhou Raises $25 Million for Dual-Action Antibiotics - ChinaBio® Today

TenNor Therapeutics of Suzhou announced a $25 million Series B financing led by Northern Light Venture Capital. TenNor is developing novel dual-acting antibiotics for unmet needs.The company's lead product, TNP-2092, is an oral capsule that treats  gastrointestinal tract bacterial infections, especially digestive diseases associated with Helicobacter pylori. The funding will be used to...

Proceed to the page: http://linkis.com/KSeWt

Similar Articles Added Earlier

Similar Articles Added Today

Latest Links Processed

  • cioneryscf on Doodle or Die

    The most addictive and hilarious doodling game on the planet. See what happens when you combine telephone with doodling.

  • elegancd4n on Doodle or Die

    The most addictive and hilarious doodling game on the planet. See what happens when you combine telephone with doodling.

  • morianhwin – Profile – Colorado Grape Growers ForumViticulture

    Colorado Grape Growers Forum - Member Profile > Profile Page. User: morianhwin, Title: New Member, About: 40 year old Master Fisher Lester Mosby from Victoriaville, likes to spend time home, and casino gambling. that covered visiting Garden Kingdom of Dess...

0/120